Amy Larsson v. Magnum Transaction Sub, LLC, Ava Weinstein-Atzram, LCSW

CourtDistrict Court, E.D. Pennsylvania
DecidedMarch 9, 2026
Docket2:24-cv-05506
StatusUnknown

This text of Amy Larsson v. Magnum Transaction Sub, LLC, Ava Weinstein-Atzram, LCSW (Amy Larsson v. Magnum Transaction Sub, LLC, Ava Weinstein-Atzram, LCSW) is published on Counsel Stack Legal Research, covering District Court, E.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Amy Larsson v. Magnum Transaction Sub, LLC, Ava Weinstein-Atzram, LCSW, (E.D. Pa. 2026).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA AMY LARSSON : CIVIL ACTION : v. : NO. 24-5506 : MAGNUM TRANSACTION SUB, LLC, : AVA WEINSTEIN-ATZRAM, LCSW : MEMORANDUM MURPHY, J. March 9, 2026 After attending a conference in May of 2022, Amy Larsson contracted COVID-19. She returned to work full-time about two weeks later, but her symptoms persisted long after. Meanwhile, defendant Lyric — Ms. Larsson’s longtime employer — was undergoing its own turmoil, preparing to separate from its parent company through a forced divestment. Ms. Larsson and her supervisor were busy with preparing the company for divestment, but things quickly changed. By December of 2022, the supervisor determined that Ms. Larsson’s role should be eliminated because it was an unnecessary layer of supervision and expense, and Lyric terminated Ms. Larsson the next month. Ms. Larsson concluded that her termination was because of her long COVID symptoms, and sued Lyric for disability discrimination, interference with her medical leave, and for creating a hostile work environment. But at the close of discovery, the record does not support Ms. Larsson’s claims. Because no reasonable jury could sustain any of Ms. Larsson’s claims, we grant Lyric’s motion for summary judgment in its entirety. I. Background Amy Larsson worked at Change Healthcare Technologies LLC, from 1994 until 2022. DI 51-3 at ¶¶ 2-3. In 2014, she began reporting to Carolyn Wukitch. Id. at ¶ 4. But in January 2021, UnitedHealth Group announced its plans to acquire Change. Id. at ¶ 9. Amid antitrust concerns and an attempt by the Department of Justice to block the acquisition, Change’s ClaimsXten business — under which both Ms. Larsson and Ms. Wukitch worked — was to be divested from Change. Id. at ¶¶ 8-11. In anticipation of ClaimsXten’s divestment, Ms. Larsson

and Ms. Wukitch assisted in preparing ClaimsXten for sale as a stand-alone business, including its structure and organization. Id. at ¶¶ 12-14. Ms. Larsson tested positive for COVID-19 on May 8, 2022 after attending a Change sales conference. Id. at ¶ 15. Ms. Larsson was out of work from May 8, 2022, when she tested positive, until May 16, 2022, when she began working part time as she continued to recover. Id. at ¶ 18. On May 23, 2022, Ms. Larsson returned to work full time. Id. at ¶ 19. Ms. Wukitch, who also contracted COVID after attending the same conference, was aware of Ms. Larsson’s illness and that she had had taken time off and worked part time off to recover from COVID. Id. at ¶¶ 16-17, 20. In September 2022, prior to the divestment, Ms. Wukitch decided that CJ Belanger, who

previously reported to Ms. Larsson, would directly report to Ms. Wukitch at the new company. Id. at ¶¶ 39-40. Ms. Wukitch was concerned that Ms. Belanger, who she viewed as a subject matter expert, would resign if required to report directly to Ms. Larsson, and the decision for Ms. Belanger to report directly to Ms. Wukitch was to ensure that Lyric was able to retain Ms. Belanger. Id. at ¶¶ 41-42, 47. Ms. Larsson was thus assigned the “go-to-market” role, and Ms. Belanger was given the “Product Management” role ahead of the divestment. Id. at ¶ 48. By October 4, 2022, ClaimsXten was purchased by defendant Magnum Transaction Sub, LLC, now known as Lyric, a healthcare technology company that “provides solutions to increase

2 payment accuracy for healthcare payers.”1 Id. at ¶¶ 1, 7. Ms. Wukitch was chosen to be Lyric’s CEO, and Ms. Larsson expressed an interest in being a part of Lyric upon its divestment. Id. at ¶¶ 30, 31. Ms. Wukitch was involved in the process of selecting employees from change that would be offered positions at Lyric, and approved of Ms. Larsson as one such employee. Id. at

¶¶ 32-33. Ms. Larsson’s role included oversight of both solution design and marketing. Id. at ¶ 129. Following her return to work in May of 2022, Ms. Larsson continued to experience COVID symptoms even after the transition to Lyric in October that year. Id. at ¶¶ 23, 56. That October, Ms. Larsson spoke with Lyric’s VP of People Solutions, Deanna Andrews. Id. at ¶ 72. During that conversation Ms. Larsson and Ms. Andrew discussed Ms. Larsson potentially “going out on disability,” what her options were, and what that process would look like, among other things. Id. Ms. Andrews encouraged Ms. Larsson to take care of herself and informed her that Lyric was still under the benefits plan that was in place at Change. Id. at ¶ 73. Change also continued to administer medical leave, including leave under the Family Medical Leave Act

(FMLA), through June of 2023. Id. at ¶ 74. At the time she spoke with Ms. Andrews, Ms. Larsson was undecided on whether to seek medical leave because she thought she might recover from her symptoms. Id. at ¶ 75. Ms. Andrews and Ms. Wukitch subsequently discussed Ms. Larsson’s health condition and continued need for flexibility in her work schedule. Id. at ¶ 82. Soon after, on November 18, 2022, Ms. Andrews left her role as VP of People Solutions and moved into doing administrative work remotely on a limited schedule. Id. at ¶ 89. Her replacement was Jeff Fix,

1 We refer to Magnum as “Lyric” throughout this memorandum. 3 who was contracted to work as Lyric’s Interim Chief Resources Officer. Id. at 91. During Mr. Fix and Ms. Andrew’s brief overlap, the two never discussed Ms. Larsson’s ongoing health problems. Id. at ¶ 93. In early December of 2022, Ms. Larsson informed Ms. Wukitch of her “Long COVID”

symptoms and that she would be seeking treatment through a long COVID program, though the specifics of that program were not discussed.2 Id. at ¶¶ 24-26. Ms. Larsson requested that Ms. Wukitch give her some flexibility with her schedule to attend doctors’ appointments or receive other treatment for her symptoms, and Ms. Wukitch granted that request. Id. at ¶¶ 27-28. During the time she was initially out of work after contracting COVID, Ms. Larsson used her “unlimited Discretionary Paid Time Off.” Id. at ¶ 21. That policy continued at Lyric following the company’s divestment from Change. Id. at ¶ 54. So, when Ms. Larsson requested flexibility in her schedule to treat her long COVID symptoms, Ms. Wukitch told Ms. Larsson that she could use her unlimited discretionary PTO to do so, which Ms. Larsson did. Id. at ¶¶ 28-29. Also in December of 2022, Ms. Wukitch asked Lyric’s board to step down from her

position as CEO, as she thought doing so was best for the business and she was concerned about the ability to spend time with her family. Id. at ¶¶ 95-96. At the request of the board, Ms. Wukitch stayed on while Lyric found a replacement, but ultimately stepped down to become Lyric’s Chief Operating Officer on in April of 2023. Id. at ¶¶ 97-99. Ms. Wukitch’s position change was accompanied by another. On December 4, 2022, Amy Churchill was hired as the senior director of marketing, which was open following the resignation of the previous director

2 Ms. Larsson had informed Ms. Wukitch of her long COVID symptoms prior to the transition to Lyric. DI 51-3 at ¶¶ 56-57. 4 of marketing.3 Id. at ¶¶ 100-101. Ms. Churchill was to “stand up the marketing function” for Lyric. Id. at ¶ 107. Ms. Wukitch held monthly leadership meetings with her leadership team, including Ms. Larsson, which were run by Ms. Wukitch and her chief of staff, Deb Hankins. Id. at ¶¶ 61-63,

108-109. In December of 2022, during one such leadership meeting, Ms. Larsson stepped out of the meeting. Id. at ¶ 110. Ms. Larsson was absent from the meeting for approximately 90 minutes to two hours. Id. When she returned to the meeting, Ms. Larsson asked questions about what she had missed while she was gone. Id. at ¶ 116. Ms. Hankins testified that while Ms. Larson asking questions was not unusual for someone who had stepped out of a leadership meeting, the length depth of her questions was, and that “annoyed” Ms. Hankins.4 Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

McDonnell Douglas Corp. v. Green
411 U.S. 792 (Supreme Court, 1973)
Faragher v. City of Boca Raton
524 U.S. 775 (Supreme Court, 1998)
Anita Deville v. Givaudan Fragrances Corp
419 F. App'x 201 (Third Circuit, 2011)
Ricardo Jalil v. Avdel Corporation
873 F.2d 701 (Third Circuit, 1989)
Dennis L. Carlson v. Township of Lower Alloways
452 F. App'x 95 (Third Circuit, 2011)
Bartos v. MHM Correctional Services, Inc.
454 F. App'x 74 (Third Circuit, 2011)
Burt N. Sempier v. Johnson & Higgins
45 F.3d 724 (Third Circuit, 1995)
David W. Callison v. City of Philadelphia
430 F.3d 117 (Third Circuit, 2005)
Doe v. C.A.R.S Protection Plus, Inc.
527 F.3d 358 (Third Circuit, 2008)
Atchison v. Sears
666 F. Supp. 2d 477 (E.D. Pennsylvania, 2009)
Ronald Ross v. Kevin Gilhuly
755 F.3d 185 (Third Circuit, 2014)
Dorothy Daniels v. Philadelphia School District
776 F.3d 181 (Third Circuit, 2015)
Fasold v. Justice
409 F.3d 178 (Third Circuit, 2005)

Cite This Page — Counsel Stack

Bluebook (online)
Amy Larsson v. Magnum Transaction Sub, LLC, Ava Weinstein-Atzram, LCSW, Counsel Stack Legal Research, https://law.counselstack.com/opinion/amy-larsson-v-magnum-transaction-sub-llc-ava-weinstein-atzram-lcsw-paed-2026.